IBM Watson Health (NYSE:IBM) is pushing back against reports that its artificial intelligence powered products deliver less than promised, claiming that the reports are unfair and ignore its capabilities. A number of news outlets, including The Wall Street Journal and STAT News, have recently published criticisms of IBM’s Watson Health offerings, claiming that its capabilities fall […]
Report: IBM Watson delivered ‘unsafe and inaccurate’ cancer recommendations
Internal documents from IBM Watson Health (NYSE:IBM) indicate that the company’s Watson for Oncology product often returns “multiple examples of unsafe and incorrect treatment recommendations,” according to a new report from STAT News. The documents come from slides presented last year by IBM Watson Health’s deputy chief health officer, according to the report, and include feedback […]
IBM Watson Health, VA extend precision oncology partnership deal
IBM Watson Health (NYSE:IBM) and the US Dept. of Veterans Affairs said today they extended their partnership using artificial intelligence to help interpret oncological data in the treatment of veteran patients. The partnership, originally signed between the two groups two years ago as part of the National Cancer Moonshot Initiative, will now be extended through to […]
Here are the top 5 medtech stories of mid-2018
A growing U.S. trade war with China and other countries casts a pall on medtech — and U.S. business in general — in mid-2018. The landscape of the medical device industry continues to evolve, though. There’s a major corporate spinout in the works, as well as a mega-merger that apparently was not to be. Read […]
Medtronic, IBM Watson Health launch AI-powered diabetes management app
Medtronic (NYSE:MDT), in partnership with IBM Watson Health, this week announced commercial availability of its AI-powered Sugar.IQ diabetes management app. Using artificial intelligence, the Sugar.IQ app evaluates how a user’s blood sugar levels respond to variables such as food intake, insulin dosing and other daily routines. Get the full story at our sister site, Drug Delivery Business […]
Report: IBM Watson Health cuts back on hospital biz
The Watson Health operation at International Business Machine (NYSE:IBM) is reportedly cutting back on the portion of its business that sells to hospitals due to a softening market for value-based healthcare offerings. Managers for IBM Watson Health told workers last week that changes to the Affordable Care Act caused hospitals to spend less on managing outcomes-based contracts, […]
IBM confirms layoffs at Watson Health
International Business Machine (NYSE:IBM) confirmed reports from last month of layoffs, but denied that the cuts affected 50% to 70% of the workforce at its Watson Health operation. The layoffs were said to involve Cleveland-based Explorys and Dallas-based Phytel, which IBM acquired in April 2015 for undisclosed amounts. Employees at medical image and clinical systems company Merge Healthcare, acquired for $1 billion in December […]
Report: IBM Watson Health slashes workforce
International Business Machine (NYSE:IBM) reportedly laid off 50% to 70% of the workforce at its Watson Health operation, primarily at recent acquisitions for which the tech giant paid at least $3.6 billion. The layoffs, according to a May 25 report in The Register, involve Cleveland-based Explorys and Dallas-based Phytel, which IBM acquired in April 2015 for undisclosed amounts. Cleveland […]
Elekta inks oncology co-selling deal with IBM Watson Health
Elekta (STO:EKTA B) said today it inked a collaborative sales deal with IBM‘s (NYSE:IBM) Watson Health through which Elekta will offer IBM’s Watson for Oncology with its cancer care solutions. With the deal, Elekta said it will begin offering the Watson for Oncology early this year as a clinical decision support solution paired with its digital cancer […]
MIT Report: IBM Watson, machine-learning plays “overhyped”
IBM (NYSE:IBM) Watson Health, and other machine-learning company’s immediate impact on healthcare may have been significantly overhyped, promoting a timeline that it may not be able to reach, according to a new article from MIT’s Technology Review. The fault lies not with the company, however, but the complexity and relative unavailability of data that it and […]
Report: While major players aim to lead AI-tech pack, major adoption still a ways off
While billions of dollars are being poured into healthcare artificial intelligence plays with major companies leading the way, the technology still has a long way to go until it’s challenging the expertise of doctors on the front lines, according to a new Xconomy report. To reach that point, companies will not only have to invest […]
MassDevice Network
@MassDevice
LinkedIn
Google+